Fully equipped lab spaces at the Switzerland Innovation Park Basel Area
Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce and have to be fully dedicated to advancing science and building the company. Unfortunately, a significant amount of the initial capital, time and energy are often spent on setting up lab infrastructure: This includes negotiations with suppliers, wait times of months until equipment arrives, getting all the necessary permits, taking on the financial risk of signing long-term lease agreements, and much more.
For that reason, BaselArea.swiss has set up fully-equipped, permitted shared lab and office space at the Switzerland Innovation Park Basel Area, which takes care of all of the above.
The lab rental package
The package includes ready-to-go labs where companies can rent one or more benches with access to shakers and incubators, fridges and freezers, autoclaves, ice machines, PCR and qPCR machines, various plate readers and imaging stations, HPLCs, rotavaps, chemical hoods, microscopes, cell culture facilities (up to BSL-2 safety levels), and much more. Also included are office desks, meeting rooms, printers, and internet access. The package comes with flexible and short-term rental contracts. And the best part is that there is a dedicated lab manager on site to take care of everything from equipment maintenance and the relevant permits to safety procedures, waste management, introductions to the various equipment, and more.
Start working right away
The lab has been in operation since 2018; the first tenants took up work in May 2018. One of them is Skyhawk Therapeutics, a Boston-based company that initially opened up a small outpost in the Basel region.
Kathleen McCarthy, CSO Skyhawk Therapeutics: “Starting research operations in Europe was an easy decision as the fully-equipped lab infrastructure in the Switzerland Innovation Park Basel Area allowed us to do so very leanly at the beginning. And it provided us with a head start so we could focus entirely on the science from day one.” Things went so well that the company has been expanding rapidly in recent months. It has already outgrown the shared lab environment and is moving into its own labs in the Technologiepark Basel.
At the same time, Versameb and Polyneuron started with small teams in the shared labs. Both companies are supported by BaseLaunch which provided them with complimentary infrastructure access for one year.
Friedrich Metzger, CEO Versameb: “Setting up our research operations in the shared lab was crucial because we could start working on advancing science right away, producing more data, and expanding our technology platform. We didn’t have to spend time or money on establishing our own lab infrastructure.” Versameb and Polyneuron are growing rapidly and have just moved into their own labs which are also located in the Technologiepark Basel.
All a company needs to do is move in. With good timing, employees can start work on the very first day and focus completely on what is most important at the beginning, namely, generating data to further advance science and build the company.
If you are interested in learning more about the lab space or start-up operations, please contact us. Or directly apply to BaseLaunch. Should you be selected, we can provide complimentary access to the lab.
Share this article
You might also be interested in
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.Read More